GRP
AQST icon

Global Retirement Partners’s Aquestive Therapeutics AQST Stock Holding History

Global Retirement Partners’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2.67K Sell
750
-750
-50% -$3.46K ﹤0.01% 2969
2024
Q3 		$7.47K Sell
1,500
-1,500
-50% -$5.84K ﹤0.01% 2400
2024
Q2 		$7.8K Buy
+3,000
New +$10K ﹤0.01% 2422

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Global Retirement Partners's AQST Position: Q4 2024 in Review

Global Retirement Partners reduced its Aquestive Therapeutics (AQST) stake by 50% in Q4 2024, selling an estimated $3.46K and leaving 750 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

Global Retirement Partners first reported a position in AQST in Q2 2024 and has held it in 3 quarters since. The position peaked at $7.8K in Q2 2024. 114 funds tracked by Wall St. Rank hold AQST as of Q4 2024.

  • Global Retirement Partners held 750 shares of Aquestive Therapeutics worth $2.67K as of Q4 2024.
  • Global Retirement Partners sold 750 Aquestive Therapeutics shares in Q4 2024, an estimated $3.46K.
  • Aquestive Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #2969 holding.
  • Global Retirement Partners first reported a position in Aquestive Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • Global Retirement Partners's Aquestive Therapeutics position peaked at $7.8K in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.